Hub : Traits :

Age at First Birth

141 significantly associated models · 28 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 153220716 154640423 4 1 6.5e-09 2.6e-09 0.12400 93 RP11-422P24.10
2 2 97351840 98736225 1 1 4.3e-18 3.2e-03 0.00049 -40 IGKV2OR2-8
3 2 99468341 101456989 1 1 5.3e-09 1.0e-08 0.26000 96 AFF3
4 3 48702606 51009435 17 5 3.9e-17 3.8e-15 NaN NaN AMIGO3 RNF123 TCTA
5 5 44048891 45516364 2 1 3.7e-10 4.8e-10 0.08320 92 RP11-53O19.3
6 5 133164490 134612693 1 1 1.4e-07 1.6e-07 0.01680 79 PHF15
7 8 35450876 36797280 1 1 7.0e-15 6.1e-03 0.01380 19 MTND6P19
8 16 89052565 90172696 1 1 5.5e-10 6.8e-05 0.28400 93 RP11-368I7.4

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Crohns Disease (2017) 5.03 3 2 6.1 0.00 1.0e+00 AMIGO3 RNF123 TCTA
Irritable Bowel Disease (IBD) 4.82 2 2 6.1 0.00 1.0e+00 AMIGO3 RNF123
Ulcerative Colitis (UC) 3.84 2 1 3.0 0.00 1.0e+00 AMIGO3 RNF123
Major Depression (MDD) 5.52 2 0 0.0 0.00 1.0e+00 RNF123 RP11-422P24.10
Reaction Time 2.13 2 0 0.0 0.00 1.0e+00 RNF123 TCTA
Verbal and Numeric Reasoning (VNR) 9.09 4 3 9.1 0.99 2.6e-04 AFF3 AMIGO3 RNF123 TCTA
Prostate Cancer 4.81 3 0 0.0 0.00 1.0e+00 AMIGO3 RNF123 RP11-422P24.10
Coronary Artery Disease (CAD) 5.01 2 1 3.0 0.00 1.0e+00 MTND6P19 RNF123
Crohns Disease (2012) 4.70 3 1 3.0 0.00 1.0e+00 AMIGO3 RNF123 TCTA
HDL Cholesterol 3.06 2 0 0.0 0.00 1.0e+00 IGKV2OR2-8 MTND6P19
Rheumatoid Arthritis 2.28 1 0 0.0 0.00 1.0e+00 AFF3
Type 2 Diabetes (T2D) 5.65 1 1 3.0 0.00 1.0e+00 IGKV2OR2-8
Ulcerative Colitis 3.47 1 1 3.0 0.00 1.0e+00 RNF123
Blood Eosinophil Count 0.83 2 0 0.0 0.00 1.0e+00 PHF15 RNF123
Blood Platelet Count 1.22 4 3 9.1 0.48 5.2e-01 IGKV2OR2-8 PHF15 RP11-368I7.4 RP11-422P24.10
Blood Red Count 2.63 5 5 15.2 -0.76 1.3e-01 AFF3 AMIGO3 RNF123 RP11-368I7.4 TCTA
Blood White Count 2.38 3 3 9.1 -1.00 3.7e-03 AMIGO3 RNF123 RP11-368I7.4
Heel T-Score 2.73 4 3 9.1 -0.15 8.5e-01 AFF3 AMIGO3 RNF123 TCTA
BMI 8.56 5 5 15.2 -0.98 1.1e-04 AFF3 AMIGO3 PHF15 RNF123 TCTA
Height 0.59 4 2 6.1 0.73 2.7e-01 AMIGO3 RNF123 RP11-422P24.10 RP11-53O19.3
Waist Hip Ratio (WHR) 1.44 2 1 3.0 0.00 1.0e+00 AMIGO3 TCTA
Systolic Blood Pressure 2.14 3 2 6.1 0.49 5.1e-01 AMIGO3 RNF123 TCTA
Smoking Status 4.07 3 1 3.0 0.63 3.7e-01 AMIGO3 RNF123 RP11-53O19.3
Allergy or Eczema 1.23 1 0 0.0 0.00 1.0e+00 RP11-422P24.10
Cardiovascular Disease 2.30 2 1 3.0 0.00 1.0e+00 RNF123 TCTA
Hypothyroidism (self reported) 2.13 1 0 0.0 0.00 1.0e+00 AFF3
Respiratory disease 3.11 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Type 2 Diabetes (T2D) 5.20 3 1 3.0 -0.10 9.0e-01 AMIGO3 RNF123 TCTA
Lung FEV1/FVC ratio 1.41 1 1 3.0 0.00 1.0e+00 AMIGO3
Lung FVC 1.63 2 1 3.0 0.00 1.0e+00 AMIGO3 RNF123
Neuroticism 3.29 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Hair Pigment 74.00 2 1 3.0 0.00 1.0e+00 IGKV2OR2-8 RP11-368I7.4
Tanning 77.54 1 1 3.0 0.00 1.0e+00 RP11-368I7.4
Hand grip strength (left) 1.38 1 0 0.0 0.00 1.0e+00 RP11-53O19.3
Number of treatments/medications taken 6.17 2 2 6.1 0.00 1.0e+00 AMIGO3 RNF123
Relative age of first facial hair 4.12 3 1 3.0 0.00 1.0e+00 AMIGO3 PHF15 RP11-368I7.4
Systolic blood pressure, automated reading 2.72 3 0 0.0 0.72 2.8e-01 AMIGO3 RNF123 TCTA
Medication: Co-codamol 5.82 2 0 0.0 0.24 7.6e-01 AMIGO3 RNF123
Medication: Metformin 3.23 2 0 0.0 0.00 1.0e+00 RNF123 TCTA
Impedance of leg (right) 3.36 3 3 9.1 -0.95 1.3e-02 AMIGO3 PHF15 RNF123
Leg fat-free mass (left) 3.17 2 2 6.1 0.91 9.0e-02 AMIGO3 RNF123
Trunk fat percentage 4.28 4 3 9.1 0.95 1.3e-02 AMIGO3 RNF123 RP11-368I7.4 TCTA
Hand grip strength (right) 1.22 1 0 0.0 0.00 1.0e+00 RP11-53O19.3
Maternal smoking around birth 5.47 3 0 0.0 0.94 5.9e-02 AMIGO3 RNF123 RP11-53O19.3
Fed-up feelings 5.78 2 1 3.0 0.86 1.4e-01 AMIGO3 RNF123
Relative age voice broke 3.76 2 0 0.0 0.00 1.0e+00 PHF15 TCTA
Taking other prescription medications 6.50 2 2 6.1 0.00 1.0e+00 AMIGO3 RNF123
Age when periods started (menarche) 5.36 3 1 3.0 -0.98 2.4e-02 AMIGO3 PHF15 RNF123
Bilateral oophorectomy (both ovaries removed) 3.71 1 0 0.0 0.00 1.0e+00 PHF15
Heel bone mineral density (BMD) T-score, automated (left) 3.97 2 2 6.1 0.00 1.0e+00 RNF123 TCTA
Qualifications: CSEs or equivalent 4.72 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
High blood pressure 1.95 2 0 0.0 0.00 1.0e+00 RNF123 TCTA
Hayfever, allergic rhinitis or eczema 1.59 1 0 0.0 0.00 1.0e+00 RP11-422P24.10
Body mass index (BMI) 10.16 5 5 15.2 0.98 6.7e-05 AFF3 AMIGO3 PHF15 RNF123 TCTA
Impedance of leg (left) 3.58 3 3 9.1 -0.94 1.8e-02 AMIGO3 PHF15 RNF123
Leg predicted mass (left) 3.14 2 2 6.1 0.91 9.1e-02 AMIGO3 RNF123
Trunk fat mass 5.04 4 3 9.1 0.97 6.8e-03 AMIGO3 RNF123 RP11-368I7.4 TCTA
Waist circumference 6.07 5 3 9.1 0.99 9.8e-05 AFF3 AMIGO3 PHF15 RNF123 TCTA
Past tobacco smoking 2.39 1 0 0.0 0.00 1.0e+00 AMIGO3
Alcohol usually taken with meals 3.41 1 0 0.0 0.00 1.0e+00 AFF3
Frequency of tenseness / restlessness in last 2 weeks 4.08 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Forced vital capacity (FVC) 2.32 3 0 0.0 0.49 4.0e-01 AMIGO3 RNF123 RP11-53O19.3
Heel bone mineral density (BMD) T-score, automated (right) 3.58 3 2 6.1 0.00 1.0e+00 AMIGO3 RNF123 TCTA
Ever unenthusiastic/disinterested for a whole week 4.82 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Qualifications: None of the above 8.63 5 2 6.1 0.99 3.9e-05 AFF3 AMIGO3 RNF123 RP11-368I7.4 RP11-53O19.3
Heart attack 3.62 1 0 0.0 0.00 1.0e+00 RNF123
Allergy 1.89 1 1 3.0 0.00 1.0e+00 RP11-422P24.10
Pain all over the body in last month 3.56 1 0 0.0 0.00 1.0e+00 AMIGO3
Diabetes (self-reported) 6.00 3 2 6.1 -0.32 6.8e-01 AMIGO3 RNF123 TCTA
Fluid intelligence score 8.95 4 3 9.1 -0.99 1.4e-04 AFF3 AMIGO3 RNF123 TCTA
Neuroticism score 3.47 1 0 0.0 0.00 1.0e+00 RNF123
Weight 5.89 5 3 9.1 0.98 1.2e-04 AFF3 AMIGO3 PHF15 RNF123 TCTA
Impedance of arm (right) 8.31 6 3 9.1 -0.85 7.3e-03 AFF3 AMIGO3 PHF15 RNF123 RP11-422P24.10 TCTA
Arm fat percentage (right) 5.71 6 2 6.1 0.97 6.4e-05 AFF3 AMIGO3 PHF15 RNF123 RP11-368I7.4 TCTA
Trunk fat-free mass 2.88 3 2 6.1 0.68 2.1e-01 AMIGO3 RNF123 RP11-368I7.4
Hip circumference 4.06 3 2 6.1 0.99 1.3e-03 AMIGO3 PHF15 RNF123
Alcohol intake versus 10 years previously 5.93 2 1 3.0 0.00 1.0e+00 AMIGO3 RNF123
Father's age at death 3.23 1 0 0.0 0.00 1.0e+00 RNF123
Worrier / anxious feelings 1.52 1 0 0.0 0.00 1.0e+00 IGKV2OR2-8
Frequency of tiredness / lethargy in last 2 weeks 3.47 2 0 0.0 0.00 1.0e+00 AFF3 AMIGO3
Number of live births 4.26 2 0 0.0 0.00 1.0e+00 RNF123 RP11-368I7.4
Forced expiratory volume in 1-second (FEV1) 2.60 2 1 3.0 0.69 3.1e-01 AMIGO3 RNF123
Pulse rate 3.24 2 1 3.0 0.00 1.0e+00 AMIGO3 TCTA
Qualifications: A levels/AS levels or equivalent 11.08 3 2 6.1 -0.96 8.7e-03 AMIGO3 RNF123 TCTA
Mouth/teeth dental problems: Dentures 4.71 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Asthma 2.77 1 0 0.0 0.00 1.0e+00 AFF3
Medication: Cholesterol lowering 3.00 2 0 0.0 0.00 1.0e+00 RNF123 TCTA
Illnesses of mother 2.20 1 0 0.0 0.00 1.0e+00 TCTA
Forced expiratory volume in 1-second (FEV1), Best measure 2.79 2 1 3.0 0.67 3.3e-01 AMIGO3 RNF123
Impedance of arm (left) 8.62 6 3 9.1 -0.81 1.5e-02 AFF3 AMIGO3 PHF15 RNF123 RP11-368I7.4 RP11-422P24.10
Arm fat mass (right) 7.20 5 3 9.1 0.98 1.8e-04 AFF3 AMIGO3 PHF15 RNF123 TCTA
Trunk predicted mass 2.84 3 2 6.1 0.66 2.3e-01 AMIGO3 RNF123 RP11-368I7.4
Standing height 0.90 4 0 0.0 -0.99 9.7e-03 AMIGO3 PHF15 RP11-368I7.4 RP11-53O19.3
Exposure to tobacco smoke at home 7.89 2 1 3.0 0.05 9.5e-01 AMIGO3 RNF123
Breastfed as a baby 4.01 1 0 0.0 0.00 1.0e+00 TCTA
Seen doctor (GP) for nerves, anxiety, tension or depression 3.12 1 0 0.0 0.00 1.0e+00 AMIGO3
Hair/balding pattern: Pattern 4 1.39 1 0 0.0 0.00 1.0e+00 RP11-422P24.10
Pulse wave reflection index 2.75 1 0 0.0 0.00 1.0e+00 AMIGO3
Ever highly irritable/argumentative for 2 days 5.13 2 0 0.0 0.32 6.8e-01 AMIGO3 RNF123
Qualifications: O levels/GCSEs or equivalent 2.94 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Medication: Paracetamol 3.36 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Medication for cholesterol, blood pressure or diabetes 4.04 3 0 0.0 0.00 1.0e+00 AMIGO3 RNF123 TCTA
Hypothyroidism/myxoedema (self-reported) 2.39 1 0 0.0 0.00 1.0e+00 AFF3
Medication: Ventolin 100micrograms inhaler 4.37 2 0 0.0 0.00 1.0e+00 AFF3 RP11-422P24.10
Chronic bronchitis/emphysema (mother) 5.14 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Forced vital capacity (FVC), Best measure 2.48 3 0 0.0 0.31 6.1e-01 AMIGO3 RNF123 RP11-53O19.3
Body fat percentage 5.55 6 3 9.1 0.97 2.0e-04 AFF3 AMIGO3 PHF15 RNF123 RP11-368I7.4 TCTA
Leg fat percentage (right) 8.20 4 3 9.1 0.97 1.5e-03 AFF3 AMIGO3 RNF123 TCTA
Arm fat-free mass (right) 4.61 3 2 6.1 0.91 3.1e-02 AMIGO3 RNF123 TCTA
Exposure to tobacco smoke outside home 4.43 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Comparative body size at age 10 1.88 1 0 0.0 0.00 1.0e+00 AMIGO3
Number of full brothers 4.14 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Wheeze or whistling in the chest in last year 7.14 3 2 6.1 1.00 3.5e-03 AFF3 AMIGO3 RNF123
Age at first live birth 12.82 5 2 6.1 -0.97 3.4e-04 AMIGO3 RNF123 RP11-368I7.4 RP11-53O19.3 TCTA
Health satisfaction 3.90 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Qualifications: College or University degree 13.50 5 3 9.1 -0.98 7.7e-05 AFF3 AMIGO3 PHF15 RNF123 RP11-368I7.4
Medication for pain relief, constipation, heartburn 3.37 1 0 0.0 0.00 1.0e+00 RNF123
Neck or shoulder pain in last month 4.16 2 0 0.0 0.00 1.0e+00 RNF123 RP11-368I7.4
Medication: Blood pressure 2.96 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Medication: Seretide 50 evohaler 3.16 1 0 0.0 0.00 1.0e+00 RNF123
Mean time to correctly identify matches 2.43 2 0 0.0 0.00 1.0e+00 RNF123 TCTA
Whole body fat mass 6.65 5 3 9.1 0.97 3.8e-04 AFF3 AMIGO3 PHF15 RNF123 TCTA
Leg fat mass (right) 8.82 5 3 9.1 0.98 1.0e-04 AFF3 AMIGO3 PHF15 RNF123 TCTA
Arm predicted mass (right) 4.58 3 2 6.1 0.91 3.3e-02 AMIGO3 RNF123 TCTA
Pulse rate, automated reading 5.79 3 3 9.1 0.00 1.0e+00 AMIGO3 RNF123 TCTA
Alcohol intake frequency. 4.41 3 2 6.1 0.00 1.0e+00 AMIGO3 RNF123 TCTA
Comparative height size at age 10 1.64 2 1 3.0 0.00 1.0e+00 AMIGO3 RP11-368I7.4
Overall health rating 7.87 2 2 6.1 0.83 1.7e-01 AMIGO3 RNF123
Chest pain or discomfort 3.36 1 0 0.0 0.00 1.0e+00 AMIGO3
Had major operations 4.05 1 0 0.0 0.00 1.0e+00 IGKV2OR2-8
Age at last live birth 11.69 2 2 6.1 -0.80 2.0e-01 AMIGO3 RNF123
Leg pain on walking 6.70 2 1 3.0 0.00 1.0e+00 AMIGO3 RNF123
Qualifications: NVQ or HND or HNC or equivalent 3.23 1 0 0.0 0.00 1.0e+00 RNF123
Knee pain experienced in last month 3.59 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Hypertension (Self-reported) 1.74 2 0 0.0 0.00 1.0e+00 RNF123 TCTA
Forced expiratory volume in 1-second (FEV1), predicted 1.43 1 0 0.0 0.00 1.0e+00 PHF15
Whole body fat-free mass 3.19 3 2 6.1 0.86 6.0e-02 AMIGO3 RNF123 TCTA
Leg fat-free mass (right) 2.76 3 2 6.1 0.98 2.3e-03 AMIGO3 PHF15 RNF123
Arm fat percentage (left) 5.96 6 3 9.1 0.97 7.7e-05 AFF3 AMIGO3 PHF15 RNF123 RP11-368I7.4 TCTA
Mood swings 5.97 2 1 3.0 0.88 1.2e-01 AMIGO3 RNF123
Long-standing illness, disability or infirmity 3.30 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Ever had bowel cancer screening 3.59 1 0 0.0 0.00 1.0e+00 RNF123
Diabetes diagnosed by doctor 4.90 3 1 3.0 -0.51 4.9e-01 AMIGO3 RNF123 TCTA
Qualifications: nursing, teaching 3.83 1 1 3.0 0.00 1.0e+00 RNF123
Mouth/teeth dental problems: Mouth ulcers 1.62 1 0 0.0 0.00 1.0e+00 AFF3
Asthma (self-reported) 2.88 2 0 0.0 0.00 1.0e+00 AFF3 RP11-422P24.10
Osteoporosis (self-reported) 2.50 1 0 0.0 0.00 1.0e+00 TCTA
Forced expiratory volume in 1-second (FEV1), predicted percentage 3.07 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Whole body water mass 3.29 3 2 6.1 0.87 5.6e-02 AMIGO3 RNF123 TCTA
Leg predicted mass (right) 2.73 3 2 6.1 0.98 2.4e-03 AMIGO3 PHF15 RNF123
Arm fat mass (left) 7.34 5 3 9.1 0.98 1.7e-04 AFF3 AMIGO3 PHF15 RNF123 TCTA
Number of self-reported non-cancer illnesses 2.47 1 0 0.0 0.00 1.0e+00 RNF123
Average weekly champagne plus white wine intake 2.00 1 0 0.0 0.00 1.0e+00 RNF123
Miserableness 6.47 2 2 6.1 -0.13 8.7e-01 AMIGO3 RNF123
Guilty feelings 5.03 2 1 3.0 0.00 1.0e+00 AMIGO3 IGKV2OR2-8
Mother's age at death 3.96 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Financial situation satisfaction 5.55 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Medication: Blood pressure 1.62 1 0 0.0 0.00 1.0e+00 TCTA
Medication: Paracetamol 3.19 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Medication: Lisinopril 1.75 1 0 0.0 0.00 1.0e+00 RP11-368I7.4
Ever smoked 2.09 1 0 0.0 0.00 1.0e+00 AMIGO3
Basal metabolic rate 3.92 3 2 6.1 0.94 1.9e-02 AMIGO3 RNF123 TCTA
Leg fat percentage (left) 8.50 5 3 9.1 0.98 1.7e-04 AFF3 AMIGO3 PHF15 RNF123 TCTA
Arm fat-free mass (left) 5.13 4 2 6.1 0.98 3.9e-04 AMIGO3 PHF15 RNF123 TCTA
Number of operations (self-reported) 4.62 2 0 0.0 0.00 1.0e+00 AMIGO3 RNF123
Average weekly beer plus cider intake 5.13 2 1 3.0 0.71 2.9e-01 AMIGO3 RNF123
Irritability 3.06 3 0 0.0 0.00 1.0e+00 AMIGO3 RNF123 RP11-53O19.3
Age started oral contraceptive pill 6.52 3 0 0.0 -0.99 9.9e-03 AFF3 RNF123 RP11-53O19.3
Diastolic blood pressure, automated reading 4.45 3 2 6.1 0.01 9.9e-01 AMIGO3 RNF123 TCTA
Ever depressed for a whole week 3.74 1 0 0.0 0.00 1.0e+00 AMIGO3
Unable to work because of sickness or disability 2.88 1 0 0.0 0.00 1.0e+00 MTND6P19
Vascular/heart problems diagnosed by doctor 2.37 2 0 0.0 0.00 1.0e+00 RNF123 TCTA
Pain experienced in last month 5.46 3 0 0.0 -1.00 3.0e-04 AMIGO3 RNF123 RP11-422P24.10
Basal cell carcinoma (self-reported) 5.34 1 1 3.0 0.00 1.0e+00 RP11-368I7.4
Impedance of whole body 6.77 4 3 9.1 -0.80 5.5e-02 AMIGO3 PHF15 RNF123 RP11-422P24.10
Leg fat mass (left) 9.00 5 3 9.1 0.98 1.0e-04 AFF3 AMIGO3 PHF15 RNF123 TCTA
Arm predicted mass (left) 5.14 3 2 6.1 0.93 2.2e-02 AMIGO3 RNF123 TCTA

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 2 0.0579 1.46
GTEx Adipose Visceral Omentum 2 0.0990 1.55
GTEx Adrenal Gland 1 0.0693 1.45
GTEx Artery Aorta 3 0.1018 1.49
GTEx Artery Coronary 1 0.0850 1.45
GTEx Artery Tibial 7 0.1879 1.51
GTEx Brain Caudate basal ganglia 2 0.2188 1.59
GTEx Brain Cerebellar Hemisphere 4 0.2710 1.55
GTEx Brain Cerebellum 5 0.2541 1.51
GTEx Brain Cortex 2 0.1944 1.66
GTEx Brain Frontal Cortex BA9 3 0.3279 1.67
GTEx Brain Hippocampus 0 0.0000 1.64
GTEx Brain Hypothalamus 0 0.0000 1.54
GTEx Brain Nucleus accumbens basal ganglia 1 0.1164 1.52
GTEx Brain Putamen basal ganglia 1 0.1610 1.61
GTEx Breast Mammary Tissue 2 0.1020 1.50
GTEx Breast Mammary Tissue (Male) 0 0.0000 1.38
GTEx Breast Mammary Tissue (Female) 2 0.1235 1.46
GTEx Cells EBV-transformed lymphocytes 1 0.0708 1.57
GTEx Cells Transformed fibroblasts 6 0.1441 1.49
GTEx Colon Sigmoid 3 0.2065 1.58
GTEx Colon Transverse 3 0.1467 1.57
GTEx Esophagus Gastroesophageal Junction 4 0.2789 1.56
GTEx Esophagus Mucosa 4 0.1215 1.54
GTEx Esophagus Muscularis 4 0.1246 1.52
GTEx Heart Atrial Appendage 3 0.1912 1.53
GTEx Heart Left Ventricle 2 0.1315 1.56
GTEx Liver 1 0.1408 1.52
GTEx Lung 5 0.1756 1.59
GTEx Muscle Skeletal 5 0.1745 1.44
GTEx Nerve Tibial 2 0.0466 1.50
GTEx Ovary 0 0.0000 1.53
GTEx Pancreas 1 0.0617 1.56
GTEx Pituitary 1 0.0900 1.49
GTEx Prostate 1 0.1206 1.50
GTEx Skin Not Sun Exposed Suprapubic 5 0.2049 1.56
GTEx Skin Sun Exposed Lower leg 5 0.1387 1.53
GTEx Small Intestine Terminal Ileum 1 0.2188 1.74
GTEx Spleen 3 0.2140 1.69
GTEx Stomach 2 0.1384 1.52
GTEx Testis 3 0.0958 1.47
GTEx Thyroid 5 0.1264 1.53
GTEx Uterus 0 0.0000 1.49
GTEx Vagina 1 0.1587 1.52
GTEx Whole Blood 2 0.1012 1.59
METSIM Adipose 6 0.1312 1.43
NTR Blood 3 0.1251 1.44
ROSMAP Brain Pre-frontal Cortex 5 0.1146 1.51
YFS Blood 3 0.0650 1.37
CommonMind Brain Pre-frontal Cortex 3 0.0561 1.47
TCGA Breast Tumor 0 0.0000 1.40
TCGA Breast Normal 3 0.0719 1.33
TCGA Ovarian Tumor 3 0.1032 1.36
TCGA Prostate Tumor 4 0.1163 1.44